Table 1.
Patient characteristics
| Patients, n | 55 |
| Gender, males/females | 23/32 |
| Age, years | 74.4 ± 5.7 |
| Body mass index | 22.4 ± 3.3 |
| Duration of T2DM, years | 17.2 ± 9.3 |
| Education, years | 9.7 ± 2.2 |
| HbAlc, % | 7.1 ± 0.8 |
| Total cholesterol, mg/dl | 203.2 ± 28.2 |
| HDL cholesterol, mg/dl | 53.7 ± 15.1 |
| Triglycerides, mg/dl | 114.1 ± 58.4 |
| Immunoreactive insulin, μU/ml | 7.6 ± 7.3 |
| Systolic BP, mm Hg | 138.0 ± 18.4 |
| Diastolic BP, mm Hg | 76.8 ± 8.0 |
| Presence of nephropathy, % | 25.4 |
| Presence of retinopathy, % | 29.1 |
| Presence of neuropathy, % | 14.5 |
| Diabetic therapy (diet/OHA/insulin), n | 16/29/10 |
| Antihypertensive treatment, % | 61.8 |
| PVH (0–3) | 0.9 ± 0.9 |
| WML (0–3) | 0.9 ± 0.8 |
| SCIs, n | 1.8 ± 1.8 |
Means ± SD. HDL = High-density lipoprotein; BP = blood pressure; OHA = oral hypoglycemic agent.